Literature DB >> 19582439

Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?

John N van den Anker, Karel Allegaert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582439      PMCID: PMC2764056          DOI: 10.1007/s00228-009-0688-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life.

Authors:  K Allegaert; V Cossey; J P Langhendries; G Naulaers; C Vanhole; H Devlieger; B Van Overmeire
Journal:  Biol Neonate       Date:  2004-07-07

Review 2.  New dosing strategies for antibacterial agents in the neonate.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Semin Fetal Neonatal Med       Date:  2004-12-01       Impact factor: 3.926

3.  Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2006-09-28       Impact factor: 2.953

4.  Individualising netilmicin dosing in neonates.

Authors:  Catherine M T Sherwin; Roland S Broadbent; Natalie J Medlicott; David M Reith
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

5.  Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.

Authors:  Catherine M T Sherwin; Sofia Svahn; Antje Van der Linden; Roland S Broadbent; Natalie J Medlicott; David M Reith
Journal:  Eur J Clin Pharmacol       Date:  2009-03-21       Impact factor: 2.953

6.  Renal function in preterm infants.

Authors:  J N van den Anker
Journal:  Eur J Pediatr       Date:  1997-07       Impact factor: 3.183

7.  Gentamicin pharmacokinetics in neonates with patent ductus arteriosus.

Authors:  J N van den Anker; G L Kearns
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

Review 8.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

9.  Renal drug clearance in preterm neonates: relation to prenatal growth.

Authors:  Karel Allegaert; Brian J Anderson; John N van den Anker; Sophie Vanhaesebrouck; Francis de Zegher
Journal:  Ther Drug Monit       Date:  2007-06       Impact factor: 3.681

  9 in total
  3 in total

1.  Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach.

Authors:  John van den Anker; Karel Allegaert
Journal:  Expert Rev Clin Pharmacol       Date:  2012-01       Impact factor: 5.045

2.  Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates.

Authors:  Isabel George; Djalila Mekahli; Maissa Rayyan; Elena Levtchenko; Karel Allegaert
Journal:  Pediatr Nephrol       Date:  2011-04-17       Impact factor: 3.714

Review 3.  Educational paper: do we need neonatal clinical pharmacologists?

Authors:  Karel Allegaert; Jean Paul Langhendries; John N van den Anker
Journal:  Eur J Pediatr       Date:  2012-05-16       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.